Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Clissold

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Behavioral Neuroscience|August 1, 1991
N-methyl-D-aspartate antagonists and working memory performance: comparison with the effects of scopolamine, propranolol, diazepam, and phenylisopropyladenosineM J Pontecorvo, D B Clissold, M F White, et al.
Frontiers in Neurology|June 6, 2017
Predicting Disability after Ischemic Stroke Based on Comorbidity Index and Stroke Severity-From the Virtual International Stroke Trials Archive-Acute CollaborationThanh G Phan, Benjamin B Clissold, Henry Ma, et al.
Frontiers in Neurology|March 22, 2018
Exploratory Use of Decision Tree Analysis in Classification of Outcome in Hypoxic-Ischemic Brain InjuryThanh G Phan, Jian Chen, Shaloo Singhal, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1993
Behavioral pharmacology of NPC 17742, a competitive N-methyl-D-aspartate (NMDA) antagonistJ Willetts, D B Clissold, T L Hartman, et al.
Brain Research Bulletin|March 1, 1991
Possible cerebroprotective and in vivo NMDA antagonist activities of sigma agentsM J Pontecorvo, E W Karbon, S Goode, et al.
Frontiers in Neurology|December 21, 2016
Examining Subcortical Infarcts in the Era of Acute Multimodality CT ImagingMindy Y Q Tan, Shaloo Singhal, Henry Ma, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1993
NPC 16377, a potent and selective sigma-ligand. II. Behavioral and neuroprotective profileD B Clissold, M J Pontecorvo, B E Jones, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1993
NPC 16377, a potent and selective sigma-ligand. I. Receptor binding, neurochemical and neuroendocrine profileE W Karbon, M E Abreu, R H Erickson, et al.
Frontiers in Neurology|March 15, 2021
COVID-19 Pandemic Impact on Care for Stroke in Australia: Emerging Evidence From the Australian Stroke Clinical RegistryDominique A Cadilhac, Joosup Kim, Emma K Tod, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Behavioral Neuroscience|August 1, 1991
N-methyl-D-aspartate antagonists and working memory performance: comparison with the effects of scopolamine, propranolol, diazepam, and phenylisopropyladenosineM J Pontecorvo, D B Clissold, M F White, et al.
Frontiers in Neurology|June 6, 2017
Predicting Disability after Ischemic Stroke Based on Comorbidity Index and Stroke Severity-From the Virtual International Stroke Trials Archive-Acute CollaborationThanh G Phan, Benjamin B Clissold, Henry Ma, et al.
Frontiers in Neurology|March 22, 2018
Exploratory Use of Decision Tree Analysis in Classification of Outcome in Hypoxic-Ischemic Brain InjuryThanh G Phan, Jian Chen, Shaloo Singhal, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1993
Behavioral pharmacology of NPC 17742, a competitive N-methyl-D-aspartate (NMDA) antagonistJ Willetts, D B Clissold, T L Hartman, et al.
Brain Research Bulletin|March 1, 1991
Possible cerebroprotective and in vivo NMDA antagonist activities of sigma agentsM J Pontecorvo, E W Karbon, S Goode, et al.
Frontiers in Neurology|December 21, 2016
Examining Subcortical Infarcts in the Era of Acute Multimodality CT ImagingMindy Y Q Tan, Shaloo Singhal, Henry Ma, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1993
NPC 16377, a potent and selective sigma-ligand. II. Behavioral and neuroprotective profileD B Clissold, M J Pontecorvo, B E Jones, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 1, 1993
NPC 16377, a potent and selective sigma-ligand. I. Receptor binding, neurochemical and neuroendocrine profileE W Karbon, M E Abreu, R H Erickson, et al.
Frontiers in Neurology|March 15, 2021
COVID-19 Pandemic Impact on Care for Stroke in Australia: Emerging Evidence From the Australian Stroke Clinical RegistryDominique A Cadilhac, Joosup Kim, Emma K Tod, et al.
Pageof 2